These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1300511)

  • 21. [18F]haloperidol binding in baboon brain in vivo.
    Yousef KA; Fowler JS; Volkow ND; Dewey SL; Shea C; Schlyer DJ; Gatley SJ; Logan J; Wolf AP
    Nucl Med Biol; 1996 Jan; 23(1):47-52. PubMed ID: 9004914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.
    Arnett CD; Shiue CY; Wolf AP; Fowler JS; Logan J; Watanabe M
    J Neurochem; 1985 Mar; 44(3):835-44. PubMed ID: 2579198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates.
    Moerlein SM; Perlmutter JS; Cutler PD; Welch MJ
    Nucl Med Biol; 1997 May; 24(4):311-8. PubMed ID: 9257329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.
    Antenor-Dorsey JA; Markham J; Moerlein SM; Videen TO; Perlmutter JS
    Nucl Med Biol; 2008 Apr; 35(3):335-41. PubMed ID: 18355689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
    Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
    Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of high affinity, aryl-substituted [18F]fluoropropylbenzamides for dopamine D-2 receptor studies.
    Mathis CA; Bishop JE; Gerdes JM; Whitney JM; Brennan KM; Jagust WJ
    Int J Rad Appl Instrum B; 1992 Jul; 19(5):571-88. PubMed ID: 1399687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
    Logan J; Wolf AP; Shiue CY; Fowler JS
    J Neurochem; 1987 Jan; 48(1):73-83. PubMed ID: 2432176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates.
    Antenor-Dorsey JA; Laforest R; Moerlein SM; Videen TO; Perlmutter JS
    Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):771-8. PubMed ID: 18071701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron-emitting N-[18F]fluoroalkyl and [18F]fluoropyrrolidinyl analogues of eticlopride as potential in vivo radioligands for dopamine D2 receptors.
    Maeda M; Sasaki S; Fukumura T; Fukuzawa E; Watanabe K; Kojima M; Tahara T; Masuda K; Ichiya Y
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1793-8. PubMed ID: 1394695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography.
    Mach RH; Nader MA; Ehrenkaufer RL; Line SW; Smith CR; Luedtke RR; Kung MP; Kung HF; Lyons D; Morton TE
    Synapse; 1996 Dec; 24(4):322-33. PubMed ID: 10638823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET Measurement of rCBF in the presence of a neurochemical tracer.
    Converse AK; Barnhart TE; Dabbs KA; DeJesus OT; Larson JA; Nickles RJ; Schneider ML; Roberts AD
    J Neurosci Methods; 2004 Jan; 132(2):199-208. PubMed ID: 14706718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET.
    Nikolaus S; Larisch R; Beu M; Forutan F; Vosberg H; Müller-Gärtner HW
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):390-5. PubMed ID: 12634967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
    Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal D2/acetylcholine interactions: PET studies of the vesamicol receptor.
    Ingvar M; Stone-Elander S; Rogers GA; Johansson B; Eriksson L; Parsons SM; Widén L
    Neuroreport; 1993 Sep; 4(12):1311-4. PubMed ID: 8260611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach.
    Delforge J; Bottlaender M; Loc'h C; Guenther I; Fuseau C; Bendriem B; Syrota A; Mazière B
    J Cereb Blood Flow Metab; 1999 May; 19(5):533-46. PubMed ID: 10326721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
    Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New fluorine-substituted analogue of eticlopride with high affinity toward dopamine D2 receptors.
    Watanabe K; Fukumura T; Sasaki S; Maeda M; Takehara S
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3211-4. PubMed ID: 1839971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.